| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
136,480,000 |
| Market
Cap: |
3.50(B) |
| Last
Volume: |
503,160 |
Avg
Vol: |
498,450 |
| 52
Week Range: |
$25.43 - $34.14 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hoffing Ellen Randi |
Director |
– • – |
2008-07-18 |
4 |
A |
$36.06 |
$12,008 |
D/D |
333 |
333 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-07-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
216,202 |
3,844,603 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-07-11 |
4 |
AS |
$34.81 |
$234,486 |
D/D |
(6,700) |
169,120 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-07-11 |
4 |
AS |
$35.32 |
$7,065 |
D/D |
(200) |
168,920 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-07-11 |
4 |
AS |
$34.49 |
$280,881 |
D/D |
(8,100) |
175,820 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-27 |
4 |
S |
$33.00 |
$158,564 |
D/D |
(4,800) |
183,920 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-27 |
4 |
S |
$32.60 |
$722,435 |
D/D |
(22,099) |
188,720 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-27 |
4 |
S |
$32.28 |
$589,816 |
D/D |
(18,124) |
210,819 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-27 |
4 |
OE |
$15.47 |
$696,506 |
D/D |
45,023 |
228,943 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-13 |
4 |
S |
$34.47 |
$280,718 |
D/D |
(8,128) |
183,920 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-13 |
4 |
S |
$34.17 |
$974,288 |
D/D |
(28,400) |
192,048 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-13 |
4 |
S |
$33.56 |
$289,494 |
D/D |
(8,500) |
220,448 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-06-13 |
4 |
OE |
$15.47 |
$696,583 |
D/D |
45,028 |
228,948 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-05-30 |
4 |
S |
$34.83 |
$238,239 |
D/D |
(6,500) |
222,448 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-05-30 |
4 |
OE |
$14.69 |
$682,436 |
D/D |
45,028 |
228,948 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-05-30 |
4 |
S |
$36.26 |
$1,405,810 |
D/D |
(38,528) |
183,920 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-05-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
376 |
3,627,392 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-05-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
444 |
3,627,768 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-05-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
824 |
3,628,212 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-05-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,659 |
3,629,036 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-05-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
7,776 |
3,631,695 |
|
- |
|
| Jandernoa Michael J |
Director |
– • – |
2008-05-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
940 |
3,639,471 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-05-16 |
4 |
S |
$33.31 |
$26,673 |
D/D |
(800) |
183,920 |
|
- |
|
| Kochan Sharon |
EVP US Generics |
• – – |
2008-05-16 |
4 |
D |
$32.93 |
$35,696 |
D/D |
(1,084) |
17,261 |
|
- |
|
| Gibbons David T |
Director |
– • – |
2008-05-16 |
4 |
S |
$32.49 |
$792,103 |
D/D |
(24,128) |
204,820 |
|
- |
|
1400 Records found
|
|
Page 39 of 56 |
|
|
0.08 (0.31%) 
